Bids Are Invited For Possible Acquisition Of Chemotherapy Drugs.

Pharmacological Group: Antineoplastics, Active Ingredient: Abemaciclib, Pharmaceutical Form: Coated Tablet, Concentration / Dosage: 150, Unit: Mg, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Supply Form: Unit, Active Ingredient: Abiraterone Acetate, Pharmaceutical Form: Tablet, Concentration / Dosage: 250, Volume: N/A, Presentation: N/A, Accessory: N/A, Pharmacological Group: Stimulant, Active Ingredient: Darbepoetin Alfa, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 500 Mcg/Ml, Unit: Mcg, Volume: 1 Ml, Presentation: Prefilled Syringe, Accessory: Na, Group Pharmacological: Hormones That Act On The Genito-Urinary System, Active Ingredient: Anastrozole, Concentration/Dosage: 1, Active Ingredient: Bicalutamide, Concentration/Dosage: 50, Presentation: Packet, 01/12/2025 - 09:55:02, Active Ingredient: Capecitabine, Concentration/Dosage: 500, Active Ingredient: Denosumab, Concentration / Dosage: 120, Presentation: Vial-Ampule, Pharmacological Group: Anticoagulants, Antagonists And Antiplatelet Agents, Active Ingredient: Eltrombopag Olamine, Active Ingredient: Enzalutamide, Pharmaceutical Form: Capsule, Concentration / Dosage: 40, Active Ingredient: Erlotinib Hydrochloride, Active Ingredient: Exemestane, Pharmaceutical Form: Dragee, Concentration / Dosage: 25, Active Ingredient: Fulvestrant, Unit: Mg/Ml, Volume: 5Ml, Active Ingredient: Goserelin Acetate, Concentration / Dosage: 10.8, Active Ingredient: Ibrutinib, Pharmaceutical Form: Hard Gelatin Capsule, Concentration / Dosage: 140, Presentation: Blister, Active Ingredient: Lenalidomide, Pharmacological Group: Immunostimulant, Active Ingredient: Lipegfilgrastim, Volume: 0.6 Ml, Presentation: Ampoule Bottle, Active Ingredient: Ruxolitinib, Active Ingredient: Tamoxifen Citrate, Concentration / Dosage: 20, Pharmacological Group: Antineoplastic, Active Ingredient: Venetoclax, Concentration / Dosage: 100